Clinical Trial Update: Clinical Trial Assessing Godex Carnitine Orotate Complex in Nonalcoholic Fatty Liver Disease Patients for Efficacy [Phase 3]

View source ↗

Summary

Phase 3 clinical trial assessing Godex Carnitine Orotate Complex for efficacy in nonalcoholic fatty liver disease is currently enrolling by invitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-alcoholic Fatty Liver Disease

Drugs mentioned

• Godex Carnitine Orotate Complex (Godex Carnitine Orotate Complex)

Snippet

Sponsor: Yoon Jun Kim | Conditions: Non-Alcoholic Fatty Liver Disease | Phase 3 | Status: ENROLLING_BY_INVITATION